© 2016 Samie, Haerian, Muniandy, Marlina, Kanthimathi, Abdullah, Ahmadian and Aziddin.The aim of this study was to evaluate the cytotoxic potential of a novel nickel(II) complex (NTC) against WiDr and HT-29 human colon cancer cells by determining the IC50 using the standard MTT assay. The NTC displayed a strong suppressive effect on colon cancer cells with an IC50 value of 6.07 ± 0.22 μM and 6.26 ± 0.13 μM against WiDr and HT-29 respectively, after 24 h of treatment. Substantial reduction in the mitochondrial membrane potential and increase in the release of cytochrome c from the mitochondria directed the induction of the intrinsic apoptosis pathway by the NTC. Activation of this pathway was further evidenced by significant activation of caspase 3/7 and 9. The NTC was also shown to activate the extrinsic pathway of apoptosis via activation of caspase-8 which is linked to the suppression of NF-κB translocation to the nucleus. Cell cycle arrest in the G1 phase was confirmed by flow cytometry and up-regulation of glutathione reductase expression was quantified by qPCR. Results of the current work indicates that NTC possess a potent cancer cell abolishing activity by simultaneous induction of intrinsic and extrinsic pathways of apoptosis in colon cancer cell lines.
Samie, N., Haerian, B. S., Muniandy, S., Marlina, A., Kanthimathi, M. S., Abdullah, N. B., … Aziddin, R. E. R. (2016). Mechanism of action of the novel nickel(II) complex in simultaneous reactivation of the apoptotic signaling networks against human colon cancer cells. Frontiers in Pharmacology, 6(JAN). https://doi.org/10.3389/fphar.2015.00313